EpiCor Plus Immunity (Fermentate derived from Saccharomyces cerevisiae)
EpiCor is a whole food fermentate derived from Saccharomyces cerevisiae that contains bioactive compounds including beta-glucans, mannoproteins, and metabolites. It works by modulating immune cell activity and supporting the gut-immune axis through stimulation of B-lymphocytes and natural killer cells.

Origin & History
EpiCor Plus Immunity is a branded dietary supplement containing EpiCor, a dried yeast fermentate derived from Saccharomyces cerevisiae (baker's yeast) through a proprietary fermentation and drying process. Originally developed for animal feed and acquired by Cargill, this postbiotic ingredient is produced from a non-GMO strain and supplied as a shelf-stable, water-soluble powder containing metabolites like short-chain fatty acids, B vitamins, minerals, and polyphenols.
Historical & Cultural Context
No historical or traditional medicine use is documented for EpiCor. This is a modern, scientifically formulated postbiotic ingredient developed through proprietary fermentation technology, with no links to traditional herbal medicine systems like Ayurveda or Traditional Chinese Medicine.
Health Benefits
• Supports balanced immune response by stimulating B-lymphocytes, salivary secretory IgA, and natural killer cells (based on pilot study evidence) • Promotes intestinal flora balance and healthy digestive function (clinical evidence level not specified) • May help maintain intestinal barrier integrity through increased butyrate production (based on preliminary animal research) • Provides immune support during seasonal challenges (clinical studies referenced but details not provided) • Delivers postbiotic compounds including B vitamins that support immune cell activity (mechanistic evidence)
How It Works
EpiCor's beta-glucans bind to pattern recognition receptors on immune cells, particularly Dectin-1 and TLR-2, activating complement pathways and enhancing phagocytic activity. The fermentate's mannoproteins and metabolites stimulate B-lymphocyte proliferation and increase secretory IgA production in mucosal tissues. Additionally, prebiotic compounds in EpiCor promote beneficial bacterial growth, strengthening intestinal barrier function through tight junction protein modulation.
Scientific Research
Research references eight human clinical trials for EpiCor including a 2008 double-blind, placebo-controlled pilot study showing immune benefits, though specific sample sizes and PMIDs are not provided in available sources. One 2019 rat study demonstrated preserved intestinal barrier function under heat stress, but detailed RCTs and meta-analyses with specific outcome data are not available in the research dossier.
Clinical Summary
A pilot study demonstrated EpiCor's ability to stimulate B-lymphocytes and increase salivary secretory IgA levels, though specific sample sizes and effect magnitudes were not detailed in available data. Clinical evidence suggests benefits for intestinal flora balance and digestive function, but the strength and scope of this evidence remains unspecified. Natural killer cell activation has been observed in preliminary research, indicating potential immune surveillance benefits. Overall, the clinical evidence base appears limited to pilot studies and requires larger, controlled trials for definitive efficacy claims.
Nutritional Profile
EpiCor is a whole food fermentate derived from Saccharomyces cerevisiae (baker's/brewer's yeast) produced through a proprietary fermentation and drying process. Typical composition per 500mg serving: Protein ~25-35% by weight (primarily yeast-derived peptides and amino acids); Carbohydrates ~40-50% by weight including beta-1,3/1,6-glucans (~15-20%), mannans, and other yeast cell wall polysaccharides; Dietary fiber ~10-15% by weight; Fat ~5-8% by weight including fatty acids. Key bioactive compounds include: polyphenols and antioxidants (ORAC value reported at approximately 52,000 µmol TE/100g, significantly higher than raw yeast); B-vitamins including thiamine (B1), riboflavin (B2), niacin (B3), pantothenic acid (B5), pyridoxine (B6), and folate in moderate concentrations; minerals including chromium, selenium (~10-15 µg/500mg), zinc (~0.5-1mg/500mg), and iron; nucleotides and nucleosides from yeast RNA breakdown; short-chain fatty acid precursors supporting butyrate production; secretory immunoglobulin-stimulating fractions not fully characterized. The fermentation process concentrates bioactive metabolites and increases bioavailability compared to non-fermented yeast; antioxidant compounds are partially water-soluble, enhancing systemic absorption. Standard clinical dose is 500mg/day.
Preparation & Dosage
Clinically studied dosage: 500 mg daily of dried yeast fermentate powder, typically taken in capsule form with a meal. Products often combine EpiCor with vitamin C (60 mg), vitamin D3 (25 mcg/1000 IU), zinc (7.5 mg), selenium (35 mcg), and olive leaf extract (33-100 mg). Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Vitamin C, Vitamin D3, Zinc, Selenium, Olive Leaf Extract
Safety & Interactions
EpiCor is generally well-tolerated as a food-derived ingredient with no major adverse effects reported in available studies. Since it's derived from baker's yeast (Saccharomyces cerevisiae), individuals with severe yeast allergies should exercise caution. No specific drug interactions have been documented, though immune-modulating effects could theoretically interact with immunosuppressive medications. Safety during pregnancy and lactation has not been established through clinical trials, so consultation with healthcare providers is recommended for these populations.